Home The Word Brain My Amedeo FAQ Privacy About Flying Publisher   

The Angels Initiative

Stroke prevention

  Liver Cirrhosis

  Free Subscription

Articles published in Z Gastroenterol

Retrieve available abstracts of 12 articles:
HTML format

Single Articles

    September 2022
  1. FRUNDT T, Schroder N, Holzemer A, Pinnschmidt H, et al
    Prevalence and risk factors of undiagnosed diabetes mellitus among gastroenterological patients: a HbA1c-based single center experience - Prevalence of undiagnosed diabetes in gastroenterological patients.
    Z Gastroenterol. 2022;60:1306-1313.
    PubMed     Abstract available

    August 2022
  2. DIETRICH CF, Shi L, Lowe A, Dong Y, et al
    Conventional ultrasound for diagnosis of hepatic steatosis is better than believed.
    Z Gastroenterol. 2022;60:1235-1248.
    PubMed     Abstract available

    January 2022
  3. KRAG A, Roskams T, Pinzani M, Mueller S, et al
    Diagnostic challenges in patients with alcohol-related liver disease.
    Z Gastroenterol. 2022;60:45-57.
    PubMed     Abstract available

    November 2021
  4. LABENZ C, Kostev K, Galle PR, Worns MA, et al
    Prescription rates of common medications in patients with decompensated cirrhosis in Germany.
    Z Gastroenterol. 2021 Nov 24. doi: 10.1055/a-1676-4822.
    PubMed     Abstract available

  5. KACZMAREK DJ, Kupczyk P, Schultheiss M, Chang J, et al
    TIPS for the management of stomal variceal bleeding due to cirrhotic and non-cirrhotic portal hypertension.
    Z Gastroenterol. 2021 Nov 5. doi: 10.1055/a-1508-6446.
    PubMed     Abstract available

    September 2021
  6. HONER ZU SIEDERDISSEN C, Schultalbers M, Wubbolding M, Lechte GS, et al
    Impact of the COVID-19 pandemic on patients with liver cirrhosis-the experience of a tertiary center in Germany.
    Z Gastroenterol. 2021;59:954-960.
    PubMed     Abstract available

    August 2021
  7. STAHMEYER JT, Hemmerling M, Burger B, Eberhard S, et al
    [Frequency of diagnosed non-alcololic fatty liver disease (NAFLD) in the German population - An analysis based on health insurance data].
    Z Gastroenterol. 2021;59:851-858.
    PubMed     Abstract available

    June 2021
  8. SCURT FG, Bose K, Canbay A, Mertens PR, et al
    [Chronic kidney injury in patients with liver diseases - Reappraising pathophysiology and treatment options].
    Z Gastroenterol. 2021;59:560-579.
    PubMed     Abstract available

    March 2021
  9. KUBESCH A, Peiffer KH, Abramowski H, Dultz G, et al
    The presence of liver cirrhosis is a strong negative predictor of survival for patients admitted to the intensive care unit - Cirrhosis in intensive care patients.
    Z Gastroenterol. 2021 Mar 16. doi: 10.1055/a-1401-2387.
    PubMed     Abstract available

    January 2021
  10. GAIRING SJ, Kloeckner R, Pitton MB, Baumgart J, et al
    Multidisciplinary approach to the complex treatment for non-cirrhotic portal hypertension - case-report-based discussion.
    Z Gastroenterol. 2021;59:43-49.
    PubMed     Abstract available

    December 2020
  11. MICHEL M, Schattenberg JM
    [Liver-specific diagnostic for non-alcoholic fatty liver disease (NAFLD) - time to replace liver biopsy?]
    Z Gastroenterol. 2020;58:1233-1240.
    PubMed     Abstract available

    November 2020
  12. MUCKE MM, Miesbach W, Peiffer KH, Mucke VT, et al
    [Management of hemostasis in gastroenterology critical care].
    Z Gastroenterol. 2020;58:1099-1106.
    PubMed     Abstract available

Thank you for your interest in scientific medicine.

AMEDEO Liver Cirrhosis is free of charge.
This policy is made possible thanks to a media sponsorship by Boehringer Ingelheim.